Hims & Hers CEO Sells $2.2 Million in Stock

Andrew Dudum, CEO of Hims & Hers Health, Inc., sold 78,859 shares of Class A Common Stock on August 14, 2026. The transaction, valued at approximately $2.2 million with a weighted average price of $28.15 per share, was non-discretionary. According to SEC Form 4 filings, the sale was executed solely to cover mandatory tax withholding obligations related to the quarterly vesting of Restricted Stock Units.

Following the sale, Dudum directly holds 1,033,177 shares and indirectly holds 8,640,870 shares through various trusts and entities. The transaction occurred during a period of volatility for the digital health platform, which had seen a one-year total stock return of -40%.

The stock sale followed a second-quarter revenue report of $753.2 million. The company also disclosed a $47.5 million accrual related to a lawsuit filed on July 29 by the Federal Trade Commission, Utah, and Los Angeles County.